• Home
  • About Us
    • AdAlta at a glance
    • Board
    • Management Team
  • Cancer Cell Therapies
    • “East to West” strategy
    • “East to West” product pipeline
  • I-Body Therapeutics
    • i-bodies
    • AD-214: A new approach to fibrotic disease
    • Fibrosis
  • Investors
    • Annual and Financial Reports
    • Presentations
    • Analyst Reports
    • ASX Announcements
    • News & Media
    • Corporate Governance
  • Contact Us

AdAlta NoM AGM 2016 final signed

AdAlta NoM AGM 2016 final signed

Archives

2018

..

2017

..

2016

..

2015

..

2014

..

2013

..

2012

..

2011

..
© 2025 AdAlta Limited Disclaimer | Privacy Policy
© 2016 AdAlta Limited